Hospital Pharmacists’ Intervention In Access To Innovative Therapies – Opportunities And Strategies: A Mixed-Method Design

Pharmacy Practice

  • Helena Coelho1Sociedade Portuguesa de Farmacêuticos dos Cuidados de Saúde, Coimbra, Portugal.
  • Susana Fraga1Sociedade Portuguesa de Farmacêuticos dos Cuidados de Saúde, Coimbra, Portugal.
  • Teresa Lopes1Sociedade Portuguesa de Farmacêuticos dos Cuidados de Saúde, Coimbra, Portugal.
  • João Fraga1Sociedade Portuguesa de Farmacêuticos dos Cuidados de Saúde, Coimbra, Portugal.
  • Susana Santos2J&J Innovative Medicine, Lda, Oeiras, Portugal.
  • Margarida Ferro3MOAI Consulting, Lisboa, Portugal.
  • Joana Sousa3MOAI Consulting, Lisboa, Portugal.

Volume 24 Issue 2 Pages 1-5

DOI: 10.18549/PharmPract.2026.2.3291

Abstract

Aim: Hospital Pharmacists play a crucial role in various activities within hospitals to ensure patient access to innovative therapies, particularly in the decision-making process. Their involvement spans from evaluating new therapies to ensuring compliance with legal and regulatory frameworks. However, the complexity of this process presents challenges that can delay patient access to necessary treatments. This study aims to evaluate the contribution of Hospital Pharmacists in the innovation pathway and to identify opportunities and strategies that enhance Hospital Pharmacists ‘ intervention in improving the access to innovative therapies. By understanding these opportunities, we can develop actionable strategies to optimize the role of Hospital Pharmacists, ensuring more timely and efficient patient access to therapeutic innovations. Methods: A mixed-method approach was employed, beginning with semi- structured interviews to gather in-depth insights from Hospital Pharmacists. Following this qualitative phase, a survey was conducted among Portuguese Hospital Pharmacists to quantify their experiences and perceptions, receiving 58 responses. The study culminated in an expert panel discussion, comprising 12 experienced Hospital Pharmacists, to reach a consensus on strategic actions. Data collection occurred between October 2021 and March 2022. Results: The survey revealed that, although Hospital Pharmacists are heavily involved in supporting decision-making for the approval of innovative therapies, there are significant opportunities to optimize this process. The expert panel identified and proposed five strategic actions aimed at improving access to legal information about innovative therapies, streamlining the approval process, and fostering collaboration among stakeholders, including regulatory bodies, healthcare providers, and pharmaceutical companies. Conclusion: The intervention of Hospital Pharmacists in the decision-making process is critical to the access pathway for innovative therapies. Implementing the identified strategies could enhance the efficiency, speed, and effectiveness of this process, ultimately benefiting patient care by ensuring quicker access to cutting-edge treatments.

Keywords

  • Hospital Pharmaceutical Service
  • Innovative Therapies
Pharmacy Practice

Loading…